Goodwin-Led Gene Editing Firm Metagenomi Raises $94M IPO
Preclinical biotech Metagenomi began trading publicly on Friday, raising $94 million by offering 6.25 million shares at $15, the low end of the $15 to $17 range it had set earlier...To view the full article, register now.
Already a subscriber? Click here to view full article